CompletedNot Applicable

Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic Cancer

United States39 participantsStarted 2018-11-15

Plain-language summary

This trial will pilot a psychosocial intervention called Conquer Fear Support (CFS) in patients with stage III-IV lung or gynecologic cancer who are experiencing fear of cancer progression. The intervention is adapted from a novel program called "Conquer Fear" which was developed by researchers in Australia. CFS may help in reducing worries, fears, and uncertainty in patients with advanced lung or gynecological cancer.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with gynecologic (GYN) and lung cancer will be recruited * Stage III or IV disease * At least 3 months from initial diagnosis * Receiving disease-focused treatment or active surveillance mode * A score of ≥ 34 on the Fear of Progression Questionnaire-Short Form (SF) or ≥ 24 on the Impact of Event Scale-Revised * All subjects must have the ability to understand and the willingness to sign a written informed consent Exclusion Criteria: * Current severe depression or psychosis; significant cognitive impairment * Patients enrolled in hospice care or who opt to receive no further disease-focused treatment * Patients who are currently receiving ongoing psychiatric treatment * Non-English speaking

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number of Eligible Participants

Timeframe: Up to 9 months

Attrition

Timeframe: Up to Week 12

Number of Sessions Attended

Timeframe: Up to 12 weeks

Percentage of Participants Who Reported Home Practice

Timeframe: Up to 12 weeks

Percentage of Participants Who Completed All Assigned Home Practice

Timeframe: Up to 12 weeks

Percentage of Participants Who Reported Attention Training Practice for at Least One Week

Timeframe: Up to 12 weeks

Trial details

NCT IDNCT03776253

SponsorCity of Hope Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-26

Results submitted2026-01-16

View on ClinicalTrials.gov More Advanced Lung Carcinoma trials

Plain-language summary

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Number of Eligible Participants

Timeframe: Up to 9 months

Attrition

Timeframe: Up to Week 12

Number of Sessions Attended

Timeframe: Up to 12 weeks

Percentage of Participants Who Reported Home Practice

Timeframe: Up to 12 weeks

Percentage of Participants Who Completed All Assigned Home Practice

Timeframe: Up to 12 weeks

Percentage of Participants Who Reported Attention Training Practice for at Least One Week

Timeframe: Up to 12 weeks